Advertisement

Topics

Global Pharmaceuticals Company Profile

04:13 EDT 25th June 2018 | BioPortfolio

Global Pharmaceuticals is the generics marketing division of IMPAX Laboratories, Inc., a technology-based specialty pharmaceutical company applying its formulation expertise and drug-delivery technology to the development of controlled-release and niche products.
Global’s multi-source product line consists of a growing range of solid oral prescription pharmaceuticals, distributed primarily through drug wholesalers, distributors, warehousing chains, and managed healthcare organizations.

The organization continues to invest in state-of-the-art equipment, people, and facilities, in order to provide the highest level of customer service. Our quality assurance team works closely with our suppliers to ensure purity, consistency, and quality of products, and we strive to bring value to our customers with innovative products in key therapeutic areas.

Global has a dedicated team of experienced professionals handling customer orders and inquiries that work to not only meet the expectations of our customers, but consistently deliver beyond expectations. Every member of our team is committed to the success and profitability of our customers. We have set the highest standards for our products, services, and people, and are proud of the organization we are building.

Location

3735 Castor Avenue
Philadelphia
Pennsylvania
19124
United States of America

Contact

Phone: (215)289-2220
Email: contracts@globalphar.com


News Articles [871 Associated News Articles listed on BioPortfolio]

BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference

RESEARCH TRIANGLE PARK, N.C. and EXTON, Pa., May 24, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (“BioCryst”) (NASDAQ:BCRX), and Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ:ID...

Rhythm Pharmaceuticals buys global rights to Takeda drug

Rhythm Pharmaceuticals purchased exclusive global rights to Takeda's T-3525770, now known as RM-853, an oral inhibitor of the -More- 

Jazz Pharmaceuticals to Present at the Goldman Sachs Global Healthcare Conference

DUBLIN, June 6, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentation at the Goldman Sachs 39th Annual Global ...

Global and China Halal Pharmaceuticals Market Research by Company, Type Application 20132025 [Report Updated: 14122017] Prices from USD $2000

SummaryHalal pharmaceuticals are those medicines that stringently adhere to Shariah law. More specifically, halal pharmaceuticals refer to medicines that should not contain any parts of animals dogs, ...

Nuevo Pharmaceuticals Picks Up Topical Head Lice Treatment In U.S.

NewsThe move to acquire Resultz from Piedmont Pharmaceuticals gives the company global product rights and opens up access to the $255 million U.S. head lice market. Resultz was FDA cleared in May 2017...

Global and North America BFS BlowFillSeal Products Market Status and Future Forecast 20132023 [Report Updated: 08022018] Prices from USD $2500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Global and North America BFS BlowFillSeal Products Market Status and Future Forecast 20132023 [Report Updated: 05012018] Prices from USD $2500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Nuvo Pharmaceuticals Picks Up Topical Head Lice Treatment In U.S.

NewsThe move to acquire Resultz from Piedmont Pharmaceuticals gives the company global product rights and opens up access to the $255 million U.S. head lice market. Resultz was FDA cleared in May 2017...

PubMed Articles [922 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Impact of Pharmaceuticals on the Environment: Risk Assessment Using QSAR Modeling Approach.

An extensive use of pharmaceuticals and the widespread practices of their erroneous disposal measures have made these products contaminants of emerging concern (CEC). Especially, active pharmaceutical...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Clinical Trials [1009 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [2167 Associated Companies listed on BioPortfolio]

Amring Pharmaceuticals Inc.

Amring Pharmaceuticals is a privately-held generic pharmaceutical company active in global markets geared to supplying unique and specialized products. The company is part of the ...

Solvay pharmaceutical, INC.

Solvay Pharmaceuticals is dedicated to optimal patient health management. Our commitment is to contribute to an increasing portion of corporate growth, revenues and profit. Within our defined therapeu...

Sigma-Tau Pharmaceuticals

Sigma-Tau Pharmaceuticals, Inc. is a U.S. based, wholly owned subsidiary of the sigma-tau Group, and is dedicated solely to the global development and commercialization of medicines for patients with ...

Gemini Pharmaceuticals Inc.

Gemini Pharmaceuticals Inc. is a global manufacturer of specialty pharmaceuticals, Over the Counter (OTC) pharmaceuticals, and dietary and nutritional supplements. With over 30 ye...

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc.

Sucampo Pharmaceuticals, Inc. is a global pharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs based on proston...

More Information about "Global Pharmaceuticals" on BioPortfolio

We have published hundreds of Global Pharmaceuticals news stories on BioPortfolio along with dozens of Global Pharmaceuticals Clinical Trials and PubMed Articles about Global Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Global Pharmaceuticals Companies in our database. You can also find out about relevant Global Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record